Colchicine enhances β adrenoceptor‐mediated vasodilation in men with essential hypertension
British Journal of Clinical Pharmacology · 2023-07 · 89 (7) · 2179-2189
DOI: 10.1111/bcp.15688 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 24.02.2023. Verfasst von Thomas S Ehlers und 7 weiteren Autor:innen. Beteiligte Einrichtung: The August Krogh Section for Human Physiology, Department of Nutrition, Exercise and Sports (Experimental Site), University of Copenhagen, Copenhagen…. Hauptthemen laut MEDLINE: Vasodilation, Acetylcholine. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Augustinus Fonden, Lundbeckfonden, HORIZON EUROPE Marie Sklodowska-Curie Actions.
Abstract (Originalsprache)
Aims
The aim of this study is to examine whether colchicine improves β adrenoceptor‐mediated vasodilation in humans by conducting a double‐blinded, placebo‐controlled intervention study. Colchicine treatment has known beneficial effects on cardiovascular health and reduces the incidence of cardiovascular disease. Studies in isolated rodent arteries have shown that colchicine can enhance β adrenoceptor‐mediated vasodilation, but this has not been determined in humans.
Methods
Middle‐aged men with essential hypertension were randomly assigned firstly to acute treatment with either 0.5 mg colchicine ( n = 19) or placebo ( n = 12). They were subsequently re‐randomized for 3 weeks of treatment with either colchicine 0.5 mg twice daily ( n = 16) or placebo ( n = 15) followed by a washout period of 48–72 h. The vasodilator responses to isoprenaline, acetylcholine and sodium nitroprusside were determined as well as arterial pressure, arterial compliance and plasma inflammatory markers.
Results
Acute colchicine treatment increased isoprenaline (by 38% for the highest dose) as well as sodium nitroprusside (by 29% main effect) ‐induced vasodilation but had no effect on the response to acetylcholine. The 3‐week colchicine treatment followed by a washout period did not induce an accumulated or sustained effect on the β adrenoceptor response, and there was no effect on arterial pressure, arterial compliance or the level of measured inflammatory markers.
Conclusion
Colchicine acutely enhances β adrenoceptor‐ and nitric oxide‐mediated changes in vascular conductance in humans, supporting that the mechanism previously demonstrated in rodents, translates to humans. The results provide novel translational evidence for a transient enhancing effect of colchicine on β adrenoceptor‐mediated vasodilation in humans with essential hypertension. Condensed abstract Preclinical studies in isolated rodent arteries have shown that colchicine can enhance β adrenoceptor‐mediated vasodilation. Here we show that this effect of colchicine can be translated to humans. Acute colchicine treatment was found to increase both isoprenaline‐ and sodium nitroprusside‐induced vasodilation. The study provides the first translational evidence for a transient β adrenoceptor‐mediated vasodilatory effect of colchicine in humans. The finding of an acute effect suggests that it may be clinically important to maintain an adequate bioavailability of colchicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The August Krogh Section for Human Physiology, Department of Nutrition, Exercise and Sports (Experimental Site), University of Copenhagen, Copenhagen, Denmark.
- Vascular Biology Group, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Biomedicine, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Thomas S Ehlers, Sophie Møller
Förderung
- Augustinus Fonden
- Lundbeckfonden
- HORIZON EUROPE Marie Sklodowska-Curie Actions
Zitieren
APA
Ehlers, T. S., van der Horst, J., Møller, S., Piil, P. K., Gliemann, L., Aalkjaer, C., Jepps, T. A., & Hellsten, Y. (2023). Colchicine enhances β adrenoceptor‐mediated vasodilation in men with essential hypertension. British Journal of Clinical Pharmacology, 89(7), 2179-2189. https://doi.org/10.1111/bcp.15688
Vancouver
Ehlers TS, van der Horst J, Møller S, Piil PK, Gliemann L, Aalkjaer C, et al. Colchicine enhances β adrenoceptor‐mediated vasodilation in men with essential hypertension. British Journal of Clinical Pharmacology. 2023;89(7):2179-2189. doi:10.1111/bcp.15688
BibTeX
@article{Ehlers2023,
author = {Ehlers, Thomas S and van der Horst, Jennifer and Møller, Sophie and Piil, Peter K and Gliemann, Lasse and Aalkjaer, Christian and Jepps, Thomas A and Hellsten, Ylva},
title = {Colchicine enhances β adrenoceptor‐mediated vasodilation in men with essential hypertension},
journal = {British Journal of Clinical Pharmacology},
year = {2023},
volume = {89},
number = {7},
pages = {2179--2189},
doi = {10.1111/bcp.15688}
}
EUVIMED